Reading a UK hair clinic advert against the rules it is written under

The rules the advert is written under

British advertising is governed by the CAP Code and enforced by the Advertising Standards Authority, and hair loss has its own published advice. Learn four rules and most UK hair-loss marketing becomes readable.

Prescription-only medicines must not be advertised to the public. That is rule 12.12, and the ASA's hair-loss advice names prescription-strength finasteride and minoxidil as falling inside it. A clinic or treatment centre may advertise a consultation — a "hair loss consultation" — but not the treatment itself.

Medicinal claims require authorisation. The ASA's guidance for the sector, published on 9 July 2026, says a claim that a product can "prevent, cure, or reverse hair loss or baldness" is likely to be seen as medicinal, and a medicinal claim requires MHRA authorisation. A non-medicinal claim such as "reduces hair loss" does not require authorisation but does require robust evidence.

Before-and-after images must be honest. They "must reflect genuine, typical outcomes and must not exaggerate results". And "testimonials do not replace clinical evidence".

Cosmetic interventions may not be aimed at children. Since November 2021, CAP rule 12.25 has prohibited cosmetic-interventions advertising from being targeted at under-18s.

Why the language is so strange

Once rule 12.12 is in the room, a whole vocabulary explains itself. "Clinically-backed treatment plan." "Personalised options." "Prescription treatments available after consultation." "Tablet and topical routes." None of those phrases names a medicine, because naming one to a public audience is not permitted.

That is compliance rather than evasion, and it is worth saying so plainly: a UK advert that talks around the drug is usually a UK advert obeying the law. The reason to learn the pattern is not to catch anyone out. It is so that you stop trying to extract from an advert information the advert is forbidden to contain, and go to the licence instead — which anyone can read, free, on the electronic medicines compendium.

What to actually look at

The claim verbs. "Prevent", "cure" and "reverse" are the words the ASA flags as medicinal. If a product with no marketing authorisation is using them, the advert has a problem. Softer verbs — reduces, supports, helps maintain — are permitted territory, and they still need evidence.

Whether evidence is named or gestured at. The ASA's guidance notes that advertisers commonly fail by relying on study abstracts, unrepresentative sample sizes and studies without control groups, and that it assesses the "overall quality and relevance, not just volume". "Backed by studies" with no study named is a sentence carrying no information.

Which condition is being described. The guidance distinguishes alopecia areata, chronic telogen effluvium and androgenetic alopecia, and warns advertisers against over-generalising between them. An advert that treats "hair loss" as one thing is making a claim about conditions with different causes and different outcomes.

Photographs. Genuine and typical, not exaggerated. A gallery selected by the seller is, by construction, not a typical sample — which is one reason no before-and-after images appear anywhere on this site.

Testimonials. The guidance is explicit that they do not substitute for evidence. A wall of quotations is a wall of quotations.

One more thing the guidance says about conditions

The ASA's 2026 advice opens by separating three things that adverts routinely blur: alopecia areata, which shows as patchy loss; chronic telogen effluvium, a temporary shedding; and androgenetic alopecia, pattern baldness. Its point to advertisers is that evidence gathered in one of those does not transfer to the others, and that an advert implying otherwise is over-generalising.

For a reader that is a practical test rather than a technicality. An advert that promises to address "hair loss" without saying which kind is either describing a product with remarkably broad evidence, or is describing a product whose evidence has been stretched across conditions it was never studied in. Asking which condition a claim refers to is the fastest way to find out which.

The part the CAP Code does not reach

Advertising rules govern claims. They do not register clinics and they do not licence doctors, and an advert that is entirely compliant tells you nothing about either.

So read the advert for what it claims, and then leave it. Whether the provider may lawfully carry out surgery is a register question — how to check a clinic on the register. Whether the individual doctor may lawfully treat you is a second and separate register — the GMC register and who counts as a surgeon. Those two searches are free, take a minute each, and answer questions no amount of copywriting can.

Complaining about one

The ASA takes complaints from the public and publishes its rulings, which is why its own advice pages cite named marketers and dated decisions. If an advert claims a product cures baldness, or shows before-and-afters that do not look typical, or names a prescription-only medicine to a public audience, the complaint route exists and it is free.

It is worth knowing that a ruling is about the advert, not about the clinic's registration or the doctor's licence. Three different systems, three different complaints, three different consequences — the ASA for the claim, the healthcare regulator for the provider, the GMC for the doctor.

The pressure that is not a claim

One last thing to read for, because the CAP Code is not the tool for it. A deadline is not a claim about efficacy, so an expiring discount, a slot that has just opened or a deposit that holds today's price does not engage any of the rules above — and it is the single most common way a cosmetic-surgery decision gets made faster than it should be.

The Care Quality Commission's counter to that is one sentence long and worth keeping in mind while reading any offer: "Take at least two weeks after your consultation with the operating surgeon to think things through before you have surgery." It also says you can change your mind at any point and ask for a second opinion. The whole sequence of checks and the fortnight that sits inside it is on hair transplants in the UK.

In short

A UK advert has been drafted around four rules, and the vagueness people find suspicious is usually the drafting. That does not make adverts a good source; it makes them a legible one. The information they are not allowed to give you is published elsewhere, by regulators, for nothing.